Skip to main content
Caplight Logo









EVerMed, Inc.

EVerMed, Inc.

Private
TokyoHealthcare & Life Scienceshttps://evermed.jp/

Last Round

Seed

Jan 28, 2025

Total Funding Raised

$2.94M

Company Overview

EVerMed, Inc. operates in Healthcare & Life Sciences and is based in Tokyo. Its latest recorded funding round was a Seed round in January 2025.

EVerMed, Inc. is a biotechnology company that develops extracellular vesicle (EV)-based therapeutics for intractable respiratory diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

EVerMed, Inc. Comparables

Compare EVerMed, Inc. with similar companies based on industry and business-model similarity.

EVerMed, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
OmniSpirant Therapeutics
84%
EXORPHIA Inc.
84%
Evox Therapeutics
77%
Book a demo to see all comparables

For institutional investors. Book with your work email.

EVerMed, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 28, 2025
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

EVerMed, Inc. Investors

Notable investors and investment history

EVerMed, Inc. investors
InvestorRounds
Nissay CapitalSeed
WASEDA University VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 28, 2025

    $3M round with Nissay Capital and WASEDA University Ventures

Book a demo to see all signals

For institutional investors. Book with your work email.

EVerMed, Inc. Filings

Explore SEC and related filing metadata, where available.

EVerMed, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about EVerMed, Inc.'s valuation, stock price, and market status.

Is EVerMed, Inc. a public or private company?

EVerMed, Inc. is a private company.

What is the current stock price of EVerMed, Inc.?

EVerMed, Inc. is a private company, so its shares have no public market price. Caplight tracks EVerMed, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is EVerMed, Inc. worth (valuation)?

Valuation information for EVerMed, Inc. is not publicly available.

Can I buy EVerMed, Inc. stock?

EVerMed, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was EVerMed, Inc.'s last funding round?

EVerMed, Inc.'s most recent funding round was Seed on January 28, 2025.

Who are the main investors in EVerMed, Inc.?

Key investors in EVerMed, Inc. include Nissay Capital, WASEDA University Ventures.

Will EVerMed, Inc. IPO soon?

No public IPO plans have been announced for EVerMed, Inc..

How can I track EVerMed, Inc. secondary market activity?

Caplight tracks bids, offers, and trades in EVerMed, Inc.'s shares on secondary markets.

Firmographic Details

HeadquartersTokyo
Year Founded2024
Last FundingJan 28, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?